HCW Biologics Inc

Research HCW Biologics Inc (HCWB) on Bullrun: market cap USD 5.90M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHCWB
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.90M
• Financial periodFY2025
• RevenueUSD 54.23K
• Revenue growth-97.9%
• Net income-USD 7.96M
• Free cash flow-USD 13.39M
• Gross margin20.0%

Valuation Snapshot

latest market cap is USD 5.90M.

About HCW Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases.

Frequently asked questions

What is HCW Biologics Inc's market cap?

HCW Biologics Inc's market capitalization is USD 5.90M.

What does HCW Biologics Inc do?

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager;